Cambridge, MA, United States of America

Khushdeep Mangat


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Khushdeep Mangat in Interleukin Research**

Introduction

Khushdeep Mangat is an accomplished inventor based in Cambridge, MA, USA. He holds a total of 2 patents, showcasing his significant contributions to the field of biomedical innovations. His work primarily revolves around the development of unique compositions and formulations for therapeutic proteins.

Latest Patents

Mangat's latest patents focus on "Compositions, formulations and interleukin production and purification." These inventions detail the cholix-IL-10 fusion proteins and their methods of use, which can elicit distinct physiological responses when administered to individuals. The innovations include oral formulations designed for site-specific release of therapeutic proteins, particularly in the small intestines or colon. His patents also describe purification methods for IL-10 delivery constructs, ensuring a high percentage remains in the biologically active dimer form during processing.

Career Highlights

Khushdeep Mangat currently works at Applied Molecular Transport Inc., where he continues to further his research and implement his innovative ideas. His work contributes significantly to the field of interleukin therapy, addressing important medical challenges in the treatment of various conditions.

Collaborations

Throughout his career, Mangat has collaborated with notable professionals in the industry, including his colleagues Randall J. Mrsny and Tahir Mahmood. These partnerships enhance the impact of his research and contribute to the advancement of his innovative solutions.

Conclusion

Khushdeep Mangat’s work exemplifies the power of innovation in the biomedical field. With his patents, he drives forward the development of therapeutic solutions that could potentially improve patient outcomes. His commitment to research and collaboration positions him as a pivotal figure in the advancement of interleukin therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…